Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Ophthalmology

Navigating the Diagnostic Process: Scans, Tissue, and Pathology

At a Glance

Chronic dacryoadenitis describes persistent lacrimal gland swelling rather than one specific disease. MRI or CT can map the gland, but biopsy and tissue testing may be needed to identify inflammation, infection, IgG4-related disease, sarcoidosis, or lymphoma.

While earlier pages explained that chronic dacryoadenitis is a “descriptive” term for a swollen lacrimal gland, this page covers the vital steps your medical team takes to find the specific cause. Because many different conditions—from autoimmune diseases to tumors—can look identical on the surface, a detailed diagnostic “roadmap” is required [1][2].

Mapping the Gland: The Role of Imaging

Before any procedure, your doctor will use specialized scans to “map” the area. These provide a high-resolution view of the gland and the surrounding structures:

  • Contrast-Enhanced MRI: This is often a preferred tool for looking at the “soft tissues” of the eye socket (orbit) [2]. It can help characterize the swelling and look for signs such as restricted diffusion [3][4].
  • CT Scan: This is particularly useful for looking at the bone surrounding the gland. Your doctor will look for bone remodeling (where the bone is thinned or pushed aside by a slow-growing mass) or bone destruction [3][5].

The Limitation of Scans: While imaging is essential for planning a workup, it is not a “crystal ball.” Imaging alone cannot provide a definitive diagnosis, as features like restricted diffusion or bone remodeling overlap between inflammation, lymphoma, and tumors [2].

The Role of Incisional Biopsy

Because scans and blood tests are often inconclusive, a biopsy—removing a small piece of the swollen gland for testing—is an important step for many patients, particularly when malignancy is a concern or disease is one-sided [1][6]. However, testing is individualized; some classic bilateral inflammatory presentations may be evaluated with clinical findings and imaging first.

In most cases requiring tissue, surgeons perform an incisional biopsy. This is a targeted procedure where only a representative sample of the tissue is taken, rather than removing the entire gland [1]. There are several ways to reach the gland, such as through a small incision in the eyelid crease or the “fornix” (the hidden pocket behind the eyelid), to ensure the most accurate sample with minimal scarring [2].

  • Risks and Recovery: The procedure can be done under local or general anesthesia. Recovery usually involves bruising and swelling. Risks include bleeding, infection, changes to eyelid position, or injury to the gland affecting tear production; vision or nerve complications are rare but possible. Always clarify with your surgeon when to call if you experience severe pain or vision changes.
  • Medication Planning: If you are already taking steroids, tell your doctor. Steroids can mask the signs of lymphoma or inflammation on a biopsy, so your doctor may plan the biopsy before starting high-dose steroids, if clinically safe.

What the Pathologist Looks For

Once the tissue sample is removed, a pathologist (a doctor who studies tissues under a microscope) performs a series of detailed checks to identify clues:

  • IgG4-Positive Cells: To check for IgG4-Related Disease, the pathologist counts specific immune cells. While a high ratio of IgG4 to total IgG cells (often >40%) is a clue, thresholds vary by organ, and these cells alone do not establish a diagnosis; patterns of scarring (fibrosis) and clinical context also matter [7][8].
  • Granulomas: These are tiny clumps of inflammatory cells. Finding “non-caseating” granulomas can be a clue pointing to sarcoidosis, though infections (like TB) and granulomatosis with polyangiitis (GPA) can also produce granulomas [9][10].
  • Flow Cytometry: This specialized test “sorts” the cells in the sample to check for lymphoma. It looks for clonality, which suggests a cancerous growth rather than a normal immune response [11][4]. A negative result does not completely rule out lymphoma, and fresh tissue must be planned for this test.
  • Special Stains and Cultures: The tissue can also be evaluated for infections depending on exposure history and clues [1][8].

A Warning About Blood Tests

It is important to know that blood tests alone should not rule out a biopsy [1]. For example, many people with IgG4-related disease have normal levels of IgG4 in their blood, even while the disease is active in their lacrimal gland [7]. Similarly, a “negative” blood test for autoimmune markers does not guarantee that the swelling is harmless. The tissue sample is often the only way to see exactly what is happening inside the gland [6][12].

If an initial biopsy is inconclusive but the swelling persists or gets worse, your doctor may even recommend a repeat biopsy to ensure a specific diagnosis like lymphoma isn’t missed [13]. Obtaining a precise answer now is the best way to ensure you receive the right treatment later.

Common questions in this guide

Why might I need a biopsy for chronic dacryoadenitis?
A biopsy may be recommended when scans or blood tests cannot identify the cause, especially when the swelling is one-sided or a tumor is a concern. Examining tissue can help distinguish inflammatory disease, infection, and lymphoma, although testing is individualized for each patient.
Can an MRI or CT scan diagnose chronic dacryoadenitis by itself?
MRI and CT can show the lacrimal gland, nearby tissues, and surrounding bone, helping doctors plan the evaluation. However, imaging findings can overlap between inflammation, lymphoma, and other tumors, so a scan alone usually cannot establish the exact diagnosis.
What does a pathologist look for in a lacrimal gland biopsy?
The pathologist may evaluate IgG4-positive cells and scarring, look for granulomas linked with conditions such as sarcoidosis, and use flow cytometry to assess for lymphoma. Special stains and cultures may also be used when infection is possible.
Can normal blood tests rule out a serious cause of lacrimal gland swelling?
No. Blood levels of IgG4 and autoimmune markers can be normal even when disease is active in the lacrimal gland. Your doctor may still recommend tissue testing when the clinical findings or imaging remain concerning.
What should I tell my surgeon before a lacrimal gland biopsy?
Tell your surgeon about all medicines, especially steroids, because steroids can alter inflammation or mask lymphoma findings in a biopsy. Ask about anesthesia, expected bruising and swelling, warning signs such as severe pain or vision changes, and when to seek help after the procedure.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Why is a biopsy recommended (or not recommended) for my specific case?
  2. 2.If we proceed with a biopsy, will you be sending fresh tissue for flow cytometry and infection testing?
  3. 3.What are the expected practical risks and recovery steps for this type of incisional biopsy?
  4. 4.How will the pathology report help distinguish between IgG4-related disease and other inflammatory conditions?
  5. 5.If the biopsy shows 'nonspecific inflammation,' what are our next steps?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    The role of biopsy in lacrimal gland inflammation: A clinicopathologic study.

    Luemsamran P, Rootman J, White VA, et al.

    Orbit (Amsterdam, Netherlands) 2017; (36(6)):411-418 doi:10.1080/01676830.2017.1352608.

    PMID: 28816552
  2. 2

    Lacrimal Gland Lesions Biopsied in a Tertiary Eye Center in Saudi Arabia: A Clinical, Radiological, Surgical, and Histological Review.

    Alturkistany W, Althaqib R, Alsulaiman N, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2022; (16()):191-200 doi:10.2147/OPTH.S331252.

    PMID: 35115759
  3. 3

    Masses of the Lacrimal Gland: Evaluation and Treatment.

    Kim JS, Liss J

    Journal of neurological surgery. Part B, Skull base 2021; (82(1)):100-106 doi:10.1055/s-0040-1722700.

    PMID: 33777623
  4. 4

    Magnetic resonance diffusion-weighted imaging in lacrimal gland lymphoma versus inflammation: A comparative study.

    Landau-Prat D, Shemesh R, Shalev D, et al.

    Indian journal of ophthalmology 2024; (72(10)):1448-1452 doi:10.4103/IJO.IJO_2109_23.

    PMID: 39331435
  5. 5

    Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland and impact on initial surgical planning.

    Esmaeli B, Lu T, Ketonen L, Debnam JM

    Frontiers in oncology 2026; (16()):1852743 doi:10.3389/fonc.2026.1852743.

    PMID: 42564044
  6. 6

    IgG4-related ophthalmic disease. Part I: background and pathology.

    McNab AA, McKelvie P

    Ophthalmic plastic and reconstructive surgery 2015; (31(2)):83-8 doi:10.1097/IOP.0000000000000363.

    PMID: 25564257
  7. 7

    The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.

    Kanda M, Nagahata K, Moriyama M, et al.

    Modern rheumatology 2025; (35(3)):542-547 doi:10.1093/mr/roae096.

    PMID: 39441008
  8. 8

    Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.

    Gan L, Luo X, Fei Y, et al.

    BMC ophthalmology 2021; (21(1)):447 doi:10.1186/s12886-021-02210-z.

    PMID: 34961492
  9. 9

    The many facets of dacryoadenitis.

    Mombaerts I

    Current opinion in ophthalmology 2015; (26(5)):399-407 doi:10.1097/ICU.0000000000000183.

    PMID: 26247137
  10. 10

    Treatment of Idiopathic Inflammatory Orbital Syndrome (IOIS) With Prominent Lacrimal Gland Involvement Using Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

    Ling HM, Chow KM

    Cureus 2024; (16(8)):e67981 doi:10.7759/cureus.67981.

    PMID: 39347244
  11. 11

    Lymphoma of the Lacrimal Gland - An International Multicenter Retrospective Study.

    Vest SD, Mikkelsen LH, Holm F, et al.

    American journal of ophthalmology 2020; (219()):107-120 doi:10.1016/j.ajo.2020.06.015.

    PMID: 32574779
  12. 12

    Assessing IgG4-related ophthalmic disease and its mimics: a comparison of ACR/EULAR, organ-specific and revised comprehensive diagnostic criteria.

    Bakshi N, Aggarwal A, Dhawan S, et al.

    Journal of clinical pathology 2025; (78(8)):554-561 doi:10.1136/jcp-2024-209552.

    PMID: 39160060
  13. 13

    Repeated Lacrimal Gland Biopsies.

    Kaushik M, Vahdani K, Neumann I, et al.

    Ophthalmic plastic and reconstructive surgery 2024; (40(4)):440-444 doi:10.1097/IOP.0000000000002614.

    PMID: 38329425

This page is for informational purposes only and does not constitute medical advice. Your ophthalmologist or surgeon should interpret your scans, biopsy, and pathology results.

Get notified when new evidence is published on chronic dacryoadenitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.